Literature DB >> 22071889

Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.

Virginie Jacquemin1, Guillaume Rieunier, Sandrine Jacob, Dorine Bellanger, Catherine Dubois d'Enghien, Anthony Laugé, Dominique Stoppa-Lyonnet, Marc-Henri Stern.   

Abstract

Ataxia telangiectasia (A-T) is a rare autosomal recessive disorder characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia, immune defects and predisposition to malignancies. A-T is caused by biallelic inactivation of the ATM gene, in most cases by frameshift or nonsense mutations. More rarely, ATM missense mutations with unknown consequences on ATM function are found, making definitive diagnosis more challenging. In this study, a series of 15 missense mutations, including 11 not previously reported, were identified in 16 patients with clinical diagnosis of A-T belonging to 14 families and 1 patient with atypical clinical features. ATM function was evaluated in patient lymphoblastoid cell lines by measuring H2AX and KAP1 phosphorylation in response to ionizing radiation, confirming the A-T diagnosis for 16 cases. In accordance with previous studies, we showed that missense mutations associated with A-T often lead to ATM protein underexpression (15 out of 16 cases). In addition, we demonstrated that most missense mutations lead to an abnormal cytoplasmic localization of ATM, correlated with its decreased expression. This new finding highlights ATM mislocalization as a new mechanism of ATM dysfunction, which may lead to therapeutic strategies for missense mutation associated A-T.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071889      PMCID: PMC3283185          DOI: 10.1038/ejhg.2011.196

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  35 in total

1.  Cleavage of ATM during radiation-induced apoptosis: caspase-3-like apoptotic protease as a candidate.

Authors:  X Tong; B Liu; Y Dong; Z Sun
Journal:  Int J Radiat Biol       Date:  2000-10       Impact factor: 2.694

2.  Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.

Authors:  Shaun P Scott; Regina Bendix; Philip Chen; Raymond Clark; Thilo Dork; Martin F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases.

Authors:  A Hotti; K Järvinen; P Siivola; E Hölttä
Journal:  Oncogene       Date:  2000-05-04       Impact factor: 9.867

4.  Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.

Authors:  Romain Micol; Lilia Ben Slama; Felipe Suarez; Loïc Le Mignot; Julien Beauté; Nizar Mahlaoui; Catherine Dubois d'Enghien; Anthony Laugé; Janet Hall; Jérôme Couturier; Louis Vallée; Bruno Delobel; François Rivier; Karine Nguyen; Thierry Billette de Villemeur; Jean-Louis Stephan; Pierre Bordigoni; Yves Bertrand; Nathalie Aladjidi; Jean-Michel Pedespan; Caroline Thomas; Isabelle Pellier; Michel Koenig; Olivier Hermine; Capucine Picard; Despina Moshous; Bénédicte Neven; Fanny Lanternier; Stéphane Blanche; Marc Tardieu; Marianne Debré; Alain Fischer; Dominique Stoppa-Lyonnet
Journal:  J Allergy Clin Immunol       Date:  2011-06-12       Impact factor: 10.793

5.  High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia.

Authors:  A Aurias; B Dutrillaux; D Buriot; J Lejeune
Journal:  Mutat Res       Date:  1980-02       Impact factor: 2.433

6.  Localization of a portion of extranuclear ATM to peroxisomes.

Authors:  D Watters; P Kedar; K Spring; J Bjorkman; P Chen; M Gatei; G Birrell; B Garrone; P Srinivasa; D I Crane; M F Lavin
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

7.  Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.

Authors:  G S Stewart; J I Last; T Stankovic; N Haites; A M Kidd; P J Byrd; A M Taylor
Journal:  J Biol Chem       Date:  2001-05-29       Impact factor: 5.157

Review 8.  Ataxia-telangiectasia, an evolving phenotype.

Authors:  Helen H Chun; Richard A Gatti
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

9.  Phenotypic cellular characterization of an ataxia telangiectasia patient carrying a causal homozygous missense mutation.

Authors:  Sandra Angèle; Anthony Laugé; Marie Fernet; Norman Moullan; Pierre Beauvais; Jérôme Couturier; Dominique Stoppa-Lyonnet; Janet Hall
Journal:  Hum Mutat       Date:  2003-02       Impact factor: 4.878

10.  Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity.

Authors:  S G Becker-Catania; G Chen; M J Hwang; Z Wang; X Sun; O Sanal; E Bernatowska-Matuszkiewicz; L Chessa; E Y Lee; R A Gatti
Journal:  Mol Genet Metab       Date:  2000-06       Impact factor: 4.797

View more
  16 in total

1.  Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.

Authors:  Kenneth L Pitter; Dana L Casey; Yue C Lu; Margaret Hannum; Zhigang Zhang; Xinmao Song; Isabella Pecorari; Biko McMillan; Jennifer Ma; Robert M Samstein; Isaac X Pei; Atif J Khan; Lior Z Braunstein; Luc G T Morris; Christopher A Barker; Andreas Rimner; Kaled M Alektiar; Paul B Romesser; Christopher H Crane; Joachim Yahalom; Michael J Zelefsky; Howard I Scher; Jonine L Bernstein; Diana L Mandelker; Britta Weigelt; Jorge S Reis-Filho; Nancy Y Lee; Simon N Powell; Timothy A Chan; Nadeem Riaz; Jeremy Setton
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

2.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

3.  Compound heterozygous variants including a novel copy number variation in a child with atypical ataxia-telangiectasia: a case report.

Authors:  Hoo Young Lee; Dae-Hyun Jang; Jae-Won Kim; Dong-Woo Lee; Ja-Hyun Jang; Joungsu Joo
Journal:  BMC Med Genomics       Date:  2021-08-17       Impact factor: 3.063

4.  Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives.

Authors:  Kathleen Claes; Julie Depuydt; A Malcolm R Taylor; James I Last; Annelot Baert; Peter Schietecatte; Veerle Vandersickel; Bruce Poppe; Kim De Leeneer; Marc D'Hooghe; Anne Vral
Journal:  Neuromolecular Med       Date:  2013-04-30       Impact factor: 3.843

Review 5.  The role of the DNA damage response kinase ataxia telangiectasia mutated in neuroprotection.

Authors:  Konstantina Marinoglou
Journal:  Yale J Biol Med       Date:  2012-12-13

6.  Targeted Next-Generation Sequencing Revealed Novel Mutations in Chinese Ataxia Telangiectasia Patients: A Precision Medicine Perspective.

Authors:  Zhao Chen; Wei Ye; Zhe Long; Dongxue Ding; Huirong Peng; Xuan Hou; Rong Qiu; Kun Xia; Beisha Tang; Hong Jiang
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

7.  Twelve novel Atm mutations identified in Chinese ataxia telangiectasia patients.

Authors:  Yu Huang; Lu Yang; Jianchun Wang; Fan Yang; Ying Xiao; Rongjun Xia; Xianhou Yuan; Mingshan Yan
Journal:  Neuromolecular Med       Date:  2013-06-27       Impact factor: 3.843

8.  Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer.

Authors:  Anika Maria Weber; Neele Drobnitzky; Aoife Maire Devery; Sivan Mili Bokobza; Richard A Adams; Timothy S Maughan; Anderson Joseph Ryan
Journal:  Oncotarget       Date:  2016-09-20

9.  Loss of ATM kinase activity leads to embryonic lethality in mice.

Authors:  Jeremy A Daniel; Manuela Pellegrini; Baeck-Seung Lee; Zhi Guo; Darius Filsuf; Natalya V Belkina; Zhongsheng You; Tanya T Paull; Barry P Sleckman; Lionel Feigenbaum; André Nussenzweig
Journal:  J Cell Biol       Date:  2012-08-06       Impact factor: 10.539

10.  Spontaneous ATM Gene Reversion in A-T iPSC to Produce an Isogenic Cell Line.

Authors:  Lucy Lin; Mavis R Swerdel; Michael P Lazaropoulos; Gary S Hoffman; Alana J Toro-Ramos; Jennifer Wright; Howard Lederman; Jianmin Chen; Jennifer C Moore; Ronald P Hart
Journal:  Stem Cell Reports       Date:  2015-11-19       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.